It is worth noting that IKBKB [24], APOB [35] and MAPK9 [41] are not only vital cholesterol metabolism regulation genes but are also often upregulated in cancer, which implies that the use of cholesterol-lowering drugs in HNSCC patients with the overexpression of these genes may be helpful. This evidence concerns the gene APOB and cancer.